Venture Capital Investors

NantOmics

NantOmics makes VC investments in high-tech companies.

Venture Investor Overview

Contact Information

Background Information

Overview

Our mission is to provide comprehensive personalized molecular solutions to inform cancer care. NantOmics, a member of the NantWorks ecosystem of companies, is a leader in molecular diagnostic testing and the first company to employ an integrated panomic approach to inform personalized treatment options for patients with cancer. Combining DNA sequencing, RNA sequencing, and quantitative proteomics, NantOmics offers extensive testing capabilities that provide a comprehensive molecular profile of a patient's cancer.

Profile

Social Media

Company News

Facebook

YouTube

Last Transaction

11/3/2016

Transaction History

Our records indicate that NantOmics invested in the VC transactions listed below. Dollar amounts are for the entire raise, which may include other investors.

Investor Contacts

Title

Name

Email & Social

Chief Executive Officer

Patrick Soon-Shiong

        

Funds

No fund closings have been recorded for this company.

Portfolio Companies

NantOmics has invested in only one tech company, according to our database records. If we are missing a portfolio company, please let us know.

Browse more venture capital investors:

Nanto Bank | NantWorks

Share this article

About Our VC & M&A Database

The venture capital investor data above is provided by VentureDeal.com, a leading provider of venture capital transaction data.

Additional Resources for Entrepreneurs

Lists of Venture Capital and Private Equity Firms

Franchise Opportunities

Contributors

Business Glossary